Scott Tarriff - Net Worth and Insider Trading
Scott Tarriff Net Worth
The estimated net worth of Scott Tarriff is at least $769,035 dollars as of 2024-12-28. Scott Tarriff is the CEO, 10% Owner of Eagle Pharmaceuticals Inc and owns about 1,538,070 shares of Eagle Pharmaceuticals Inc (EGRX) stock worth over $769,035. Details can be seen in Scott Tarriff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott Tarriff has not made any transactions after 2023-11-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott Tarriff
Scott Tarriff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott Tarriff owns 3 companies in total, including Eagle Pharmaceuticals Inc (EGRX) , Alaunos Therapeutics Inc (TCRT) , and Theriva Biologics Inc (TOVX) .
Click here to see the complete history of Scott Tarriff’s form 4 insider trades.
Insider Ownership Summary of Scott Tarriff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EGRX | Eagle Pharmaceuticals Inc | 2023-11-02 | director & President and CEO |
| TCRT | Alaunos Therapeutics Inc | 2015-09-25 | director |
| TOVX | Theriva Biologics Inc | 2019-12-04 | director |
Scott Tarriff Latest Holdings Summary
Scott Tarriff currently owns a total of 1 stock. Scott Tarriff owns 1,538,070 shares of Eagle Pharmaceuticals Inc (EGRX) as of November 2, 2023, with a value of $769,035.
Latest Holdings of Scott Tarriff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EGRX | Eagle Pharmaceuticals Inc | 2023-11-02 | 1,538,070 | 0.50 | 769,035 |
Holding Weightings of Scott Tarriff
Scott Tarriff Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott Tarriff has made a total of 4 transactions in Eagle Pharmaceuticals Inc (EGRX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Eagle Pharmaceuticals Inc is the sale of 21,619 shares on November 2, 2023, which brought Scott Tarriff around $299,207.
Insider Trading History of Scott Tarriff
- 1
Scott Tarriff Trading Performance
Scott Tarriff Ownership Network
Scott Tarriff Owned Company Details
What does Eagle Pharmaceuticals Inc do?
Who are the key executives at Eagle Pharmaceuticals Inc?
Scott Tarriff is the director & President and CEO of Eagle Pharmaceuticals Inc. Other key executives at Eagle Pharmaceuticals Inc include EVP & Chief Commercial Officer Michael Shawn Moran , Chief Medical Officer Judith Ng-cashin , and Chief Financial Officer Brian Joseph Cahill .
Eagle Pharmaceuticals Inc (EGRX) Insider Trades Summary
Over the past 18 months, Scott Tarriff made 2 insider transaction in Eagle Pharmaceuticals Inc (EGRX) with a net sale of 41,864.
In summary, during the past 3 months, insiders sold 0 shares of Eagle Pharmaceuticals Inc (EGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 41,864 shares of Eagle Pharmaceuticals Inc (EGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 41,864 shares.
Eagle Pharmaceuticals Inc (EGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eagle Pharmaceuticals Inc Insider Transactions
Scott Tarriff Mailing Address
Above is the net worth, insider trading, and ownership report for Scott Tarriff. You might contact Scott Tarriff via mailing address: 28 Tudor Rose Terrace, Mahwah Nj 07430.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
